VTGN
#4758
Vistagen Therapeutics, Inc. - Common Stock
0.2 4 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
+9.09%
6 month change
-53.41%
Year Change
-53.41%
Previous Close
0.2 4
Open
0.2 4
Low
0.2 4
High
0.2 4
Volume
14
Financials
- Market Capitalization 9.85 M
- Employee 41
- Founded 1998
- CEO N/A
- Website www.vistagen.com
- Headquarter Nevada, United States
- FIGI BBG000BB33L9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.31
Price to sales ratio
17.15
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4752 |  XCUR Exicure, Inc. - Common Stock | 1.57 USD | -9.25% | -8.19% | -22.28% | -77.86% | 10.01 M USD | ||
| 4755 |  LEXX Lexaria Bioscience Corp. - Common Stock | 0.40 USD | -24.53% | -29.82% | -29.82% | -54.02% | 9.91 M USD | ||
| 4762 |  CRIS Curis, Inc. - Common Stock | 4.96 USD | -0.40% | -0.40% | +853.85% | +198.80% | 9.67 M USD | ||
| 4763 |  TOVX Theriva Biologics, Inc. Common Stock | 0.21 USD | 0.00% | -4.55% | -16.00% | -15.19% | 9.64 M USD |
Frequently asked questions about Vistagen Therapeutics, Inc. - Common Stock
What is the Vistagen Therapeutics, Inc. - Common Stock stock price today?
The current price of Vistagen Therapeutics, Inc. - Common Stock (VTGN) is 0.24. Over the past 24 hours, the stock has changed by 0.00%. Follow the VTGN chart for real-time price dynamics.
What is the stock ticker of Vistagen Therapeutics, Inc. - Common Stock?
Vistagen Therapeutics, Inc. - Common Stock trades under the ticker VTGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vistagen Therapeutics, Inc. - Common Stock stock going up?
VTGN has changed by +9.09% over the last week, +9.09% over the last month, and -53.41% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Vistagen Therapeutics, Inc. - Common Stock?
Vistagen Therapeutics, Inc. - Common Stock currently has a market capitalization of 9.85 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Vistagen Therapeutics, Inc. - Common Stock earnings last quarter?
Last quarter, Vistagen Therapeutics, Inc. - Common Stock reported earnings of -0.37 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Vistagen Therapeutics, Inc. - Common Stock revenue for the last quarter?
Vistagen Therapeutics, Inc. - Common Stock reported quarterly revenue of 464 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Vistagen Therapeutics, Inc. - Common Stock net income for the last quarter?
Vistagen Therapeutics, Inc. - Common Stock reported net income of -16.27 M for the last quarter. The previous quarter showed -18.9 M, which means net income changed by +13.89%.
How many employees does Vistagen Therapeutics, Inc. - Common Stock have?
As of the latest available data, Vistagen Therapeutics, Inc. - Common Stock has 41 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vistagen Therapeutics, Inc. - Common Stock EBITDA?
Vistagen Therapeutics, Inc. - Common Stock EBITDA is -16.67 M, and its EBITDA margin is -3 592.89%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vistagen Therapeutics, Inc. - Common Stock stock?
You can buy Vistagen Therapeutics, Inc. - Common Stock (VTGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vistagen Therapeutics, Inc. - Common Stock stock?
Investing in Vistagen Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VTGN chart and related analysis on metatrader.com as part of your research.